Within the framework of FSHD University, AMRA’s SVP Global Development and Marketing Rosemary Shull presented at the webinar “Whole-body MRI in FSH muscular dystrophy research”.
The gist of the webinar as described by FSHD Society:
We refer often to MRI (magnetic resonance imaging) as an almost magical way to peer inside the body and see what’s going on with our muscles. MRI is a key component of Fulcrum’s ReDUX4 clinical trial for FSH muscular dystrophy. But do you really understand how this technology works, and what it can and can’t reveal? Is it useful only for research, or does it have a place in healthcare for FSHD? At this month’s webinar, Rosemary Shull of AMRA, the Swedish company that is working with Fulcrum, will explain how MRI works and the role it is playing in the ReDUX4 trial. She’ll be sharing some stunning images that are enabling researchers to visualize what is going on with FSHD as never before.
